| Symbol |
Name |
|
ADORA2B
|
adenosine A2b receptor
|
|
ALX1
|
ALX homeobox 1
|
|
APBB2
|
amyloid beta (A4) precursor protein-binding, family B, member 2
|
|
ARL4C
|
ADP-ribosylation factor-like 4C
|
|
BAX
|
BCL2-associated X protein
|
|
CARD10
|
caspase recruitment domain family, member 10
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
|
CCNB1
|
cyclin B1
|
|
CD9
|
CD9 molecule
|
|
CDC20
|
cell division cycle 20
|
|
CDKN3
|
cyclin-dependent kinase inhibitor 3
|
|
CKS2
|
CDC28 protein kinase regulatory subunit 2
|
|
CLU
|
clusterin
|
|
CTSC
|
cathepsin C
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
|
CXCL6
|
chemokine (C-X-C motif) ligand 6
|
|
DIRAS3
|
DIRAS family, GTP-binding RAS-like 3
|
|
EGFR
|
epidermal growth factor receptor
|
|
EPHA2
|
EPH receptor A2
|
|
EPHB6
|
EPH receptor B6
|
|
FLNB
|
filamin B, beta
|
|
FOXF2
|
forkhead box F2
|
|
FOXO1
|
forkhead box O1
|
|
FZD2
|
frizzled class receptor 2
|
|
GEM
|
GTP binding protein overexpressed in skeletal muscle
|
|
GPRC5A
|
G protein-coupled receptor, class C, group 5, member A
|
|
GPRC5B
|
G protein-coupled receptor, class C, group 5, member B
|
|
ICK
|
intestinal cell (MAK-like) kinase
|
|
IL33R
|
interleukin 33 receptor
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGA3
|
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor)
|
|
ITGA6
|
integrin, alpha 6
|
|
KRT18
|
keratin 18, type I
|
|
LAMA3
|
laminin, alpha 3
|
|
LGALS3BP
|
lectin, galactoside-binding, soluble, 3 binding protein
|
|
LIFR
|
leukemia inhibitory factor receptor alpha
|
|
LPXN
|
leupaxin
|
|
MAP4K2
|
mitogen-activated protein kinase kinase kinase kinase 2
|
|
MAPRE2
|
microtubule-associated protein, RP/EB family, member 2
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP3
|
matrix metallopeptidase 3
|
|
NMT2
|
N-myristoyltransferase 2
|
|
NMU
|
neuromedin U
|
|
NR2F2
|
nuclear receptor subfamily 2, group F, member 2
|
|
ORC2
|
origin recognition complex, subunit 2
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
|
PKIA
|
protein kinase (cAMP-dependent, catalytic) inhibitor alpha
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PPL
|
periplakin
|
|
PPT2
|
palmitoyl-protein thioesterase 2
|
|
PRSS3
|
protease, serine, 3
|
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4)
|
|
PTGFR
|
prostaglandin F receptor (FP)
|
|
PTPRF
|
protein tyrosine phosphatase, receptor type, F
|
|
PTPRK
|
protein tyrosine phosphatase, receptor type, K
|
|
PTTG1
|
pituitary tumor-transforming 1
|
|
RELN
|
reelin
|
|
RHOBTB3
|
Rho-related BTB domain containing 3
|
|
RRAS2
|
related RAS viral (r-ras) oncogene homolog 2
|
|
SDCBP
|
syndecan binding protein (syntenin)
|
|
SHC3
|
SHC (Src homology 2 domain containing) transforming protein 3
|
|
SPOCK1
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 1
|
|
STAC
|
SH3 and cysteine rich domain
|
|
SYNGR3
|
synaptogyrin 3
|
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
TM4SF1
|
transmembrane 4 L six family member 1
|
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
|
TNFRSF21
|
tumor necrosis factor receptor superfamily, member 21
|
|
TNNT1
|
troponin T type 1 (skeletal, slow)
|
|
TP53
|
tumor protein p53
|
|
TSPAN8
|
tetraspanin 8
|
|
TUBB2B
|
tubulin, beta 2B class IIb
|